Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Ozeroff Christopher David
S.V.P., General Counsel at Oruka Therapeutics. Filing since 18 Sep 2015.
CIK 0001454996
Company
Date
Role
Action
Shares
Amount
Of holding
ORKA
Oruka Therapeutics, Inc.
22 Nov 2021
S.V.P., General Counsel
Bought
50,000
$113.21K
×52
ORKA
Oruka Therapeutics, Inc.
4 Apr 2017
S.V.P., General Counsel
Sold, plan not stated
418
$1.01K
2.3%
ORKA
Oruka Therapeutics, Inc.
28 Feb 2017
S.V.P., General Counsel
Sold, plan not stated
465
$1.21K
2.5%
ORKA
Oruka Therapeutics, Inc.
20 Sep 2016
S.V.P., General Counsel
Sold, plan not stated
1,185
$3.42K
6.1%
ORKA
Oruka Therapeutics, Inc.
5 Apr 2016
S.V.P., General Counsel
Sold, plan not stated
366
$1.29K
1.8%
ORKA
Oruka Therapeutics, Inc.
1 Mar 2016
S.V.P., General Counsel
Sold, plan not stated
458
$1.61K
2.2%
ORKA
Oruka Therapeutics, Inc.
18 Sep 2015
S.V.P., General Counsel
Sold, plan not stated
1,129
$7.14K
5.2%
7 decisions on file.
